When patients use both treatments concurrently, several precautions are warranted : Injection site management : Rotate sites systematically and avoid administering both injections in the same anatomical area on the same day Gastrointestinal monitoring : Tirzepatide's GI effects may be misattributed to lipotropic injections, potentially leading to inappropriate dose adjustments Hydration emphasis : Ensure adequate fluid intake given tirzepatide's potential to cause dehydration through GI effects Medication adjustments : Consider reducing doses of insulin or sulfonylureas when initiating tirzepatide to mitigate hypoglycemia risk Realistic expectations : Counsel patients that weight loss benefits derive primarily from tirzepatide's pharmacological action Cost considerations : Lipotropic injections represent additional out-of-pocket expense without proven incremental benefit Patients should seek immediate medical attention for severe or persistent abdominal pain (possible pancreatitis), right upper quadrant pain with fever or jaundice (gallbladder disease), signs of allergic reaction, persistent vomiting leading to dehydration, or symptomatic hypoglycemia if on insulin/sulfonylureas
Refrigerate at 28 C, protect from light, and observe the beyond-use window
Curcumin A polyphenolic compound produced in the Curcuma longa tree, Curcumin (Figure 12), has anti-inflammatory and antioxidant properties
10.1016/j.jpeds.2021.08.075 233
Adding a second peptide to an Epithalon protocol moves the stack to $795 per cycle
This approach has many benefits: It improves anemia and related symptoms
